In our proteomics study, Gal-9 was not identified, but in accordance with these results, the Galectin-3-binding protein (Gal-3BP) with a role in innate immune response to viruses (70) was significantly overrepresented in all symptomatic COVID-19 cohorts (Supplementary Data 1). The gene discussed is LGALS3BP; the disease is COVID-19.